Amedisys (AMED) Reports Mixed Q1 Earnings; Guides FY09
More News related to AMED
- Amedisys (AMED) Releases Review Report from Marwood Group Advisory
- Amedisys Releases Report from Marwood Group Advisory
- Amedisys to Present at the Oppenheimer 20th Annual Healthcare Conference
- Stifel Nicolaus Upgrades Amedisys (AMED) to Buy
- Amedisys (AMED) options active after reaffirming FY2009 guidance
Amedisys, Inc. (NASDAQ: AMED) reports Q1 EPS of $0.99, 2 cents better than the analyst estimate of $0.97. Revenue for the quarter was $341.8 million, versus the consensus of $345.46 million.
Sees FY09 $1.425-$1.475 billion, versus the consensus of $1.46 billion. EPS for the year are expected to be $4.10-$4.30, versus the Street estimate of $4.18.
Related Categories
EarningsGuidance
Stocks Mentioned
-1.18Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
